The objective of this study was to investigate this concern by comparing the antibody response generated by different revaccination programmes
These results indicate that the frequent administration of MIXOHIPRA® H for revaccination of adult rabbits does not decrease the pre-existing antibody response.
This practice might help to compensate for administration mistakes and to keep up with vaccination, thus avoiding generating subpopulations of negative animals in the case of farms with high replacement rates.
Recombinant vaccine against rabbit haemorrhagic disease (RHD) caused by the classical (RHDV) and variant (RHDV2) strains, including highly virulent strains, in an emulsion for injection.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Live heterologous vaccine against myxomatosis, in injectable freeze-dried tablet.
Live homologous vaccine against myxomatosis, in injectable freeze-dried tablet
Inactivated vaccine against the classic strain of rabbit haemorrhagic disease (RHDV1), in injectable emulsion
Enrofloxacin, in oral solution, animal medicine, animal medicines, medicine for rabbits, rabbit medicine, medicine for poultry
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
